Target intelligence / Profile preview

Polyhomeotic-like protein 3 (PHC3)

Target
PHC3
Molecular classification
Polycomb group protein, epigenetic regulator, chromatin modifier, transcriptional repressor, PRC1 complex component
01

Overview

Polyhomeotic-like protein 3 (PHC3) is a member of the Polycomb group protein family, acting as a component of the human Polycomb repressive complex 1 (PRC1)-related hPRC-H complex, mediating gene silencing through epigenetic regulation. PHC3 contains a (Cys)4-type zinc finger and a sterile alpha motif (SAM) domain, both important for protein-protein interactions involved in organizing higher-order chromatin structure and recruiting chromatin-remodeling complexes. PHC3 regulates the repression of transcription in quiescent (G₀) cells, interacting with other Polycomb proteins (such as YY1, M33, and Bmi1) and the transcription factor E2F6, with which it forms complexes that silence E2F and Myc target promoters. Loss-of-function mutations, loss of expression, and deletion of the PHC3 gene have been linked to human osteosarcoma, suggesting its role as a tumor suppressor gene. There is no current evidence for direct pharmacological targeting of PHC3, but its loss serves as a potential biomarker for predisposition to or progression of certain cancers[1][2][3].

Other names
EDR3PH3hPH3FLJ12967FLJ12729HPH3Early development regulatory protein 3Homolog of polyhomeotic 3early development regulator 3polyhomeotic like 3polyhomeotic-like protein 3
02

Biological functions

Chromatin organizationgene silencingregulation of transcriptioncell cycle regulationmaintenance of cellular quiescence
03

Disease associations

Cancer (notably osteosarcoma; acts as a tumor suppressor)other potential roles in differentiation-related disease
04

Safety considerations

Loss of PHC3 function may disrupt cell cycle arrest and promote tumorigenesis in specific cancers, particularly osteosarcoma
05

Biomarkers

Potential tumor suppressor loss in osteosarcoma tumors

Beyond the preview

Go deeper on Polyhomeotic-like protein 3 (PHC3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Polyhomeotic-like protein 3 (PHC3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call